Andrea I. Perez-Loaiza
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Triumphs and challenges in exploiting poly(ADP-ribose) polymerase inhibition to combat triple-negative breast cancer.
Journal: Journal of cellular physiology
Published: January 12, 2023
New Treatments in Renal Cancer: The AhR Ligands.
Journal: International journal of molecular sciences
Published: April 01, 2020
AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells.
Journal: Journal of cellular physiology
Published: March 19, 2018
N4 -aryl substituted thiosemicarbazones derived from 1-indanones as potential anti-tumor agents for breast cancer treatment.
Journal: Journal of cellular physiology
Published: August 08, 2017
In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells.
Journal: Journal of cellular biochemistry
Published: February 24, 2017
The Immune System As a New Possible Cell Target for AFP 464 in a Spontaneous Mammary Cancer Mouse Model.
Journal: Journal of cellular biochemistry
Published: January 26, 2017
Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
Journal: International journal of oncology
Published: December 10, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026